1 Result for "

BGC0222

" in MedChemExpress (MCE) Product Catalog:
Products (1)

1 Results for "BGC0222" in MCE Product Catalog:

Cat. No.: HY-P10783
Research Areas:  

Cancer

BGC0222 is a novel prodrug of Irinotecan (HY-16562). BGC0222, as a PEG-cRGD-conjugated Irinotecan (HY-16562) derivative, could slowly and steadily release Irinotecan (HY-16562). BGC0222 binds to αVβ3 with IC50 values of 4.25 μM (αVβ3) and 58.7 μM (αVβ5). BGC0222 possesses the property of inducing neovascularization. BGC0222 exhibits good antiproliferation activity in many tumors .
loading...
    loading...